OPTN/SRTR 2012 Annual Data Report: heart

被引:55
作者
Colvin-Adams, M.
Smith, J. M.
Heubner, B. M.
Skeans, M. A.
Edwards, L. B.
Waller, C.
Schnitzler, M. A. [1 ,2 ]
Snyder, J. J.
Israni, A. K.
Kasiske, B. L.
机构
[1] Minneapolis Med Res Fdn Inc, Sci Registry Transplant Recipients, Minneapolis, MN USA
[2] St Louis Univ, Sch Med, Ctr Outcomes Res, St Louis, MO USA
关键词
End-stage heart failure; heart transplant; transplant outcomes; ventricular assist device;
D O I
10.1111/ajt.12583
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
The number of heart transplants performed annually continues to increase gradually, and the number of adult candidates on the waiting list increased by 25% from 2004 to 2012. The heart transplant rate among active adult candidates peaked at 149 per 100 wait-list years in 2007 and has been declining since; in 2012, the rate was 93 heart transplants per 100 active wait-list years. Increased waiting times do not appear to be correlated with an overall increase in wait-list mortality. Since 2007, the proportion of patients on life support before transplant increased from 48.6% to 62.7% in 2012. Medical urgency categories have become less distinct, with most patients listed in higher urgency categories. Approximately 500 pediatric candidates are added to the waiting list each year; the number of transplants performed each year increased from 274 in 1998 to 372 in 2012. Graft survival in pediatric recipients continues to improve; 5-year graft survival for transplants performed in 2007 was 78.5%. Medicare paid for some or all of the care for nearly 40% of heart transplant recipients in 2010. Heart transplant appears to be more expensive than ventricular assist devices for managing end-stage heart failure, but is more effective and likely more cost-effective.
引用
收藏
页码:113 / 138
页数:26
相关论文
empty
未找到相关数据